Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03496636 · ClinicalTrials.gov registry record · NA

Autologous Ovarian Tissue Transplantation

A NA study of Female Infertility, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT03496636 is a NA study of Female Infertility that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 5 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03496636, a NA study of Female Infertility, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

Chemotherapy and radiation for cancer and other conditions can cause infertility. Several centers around the world are cryopreserving ovarian tissue from these patients though an experimental protocol, including the Fertility Preservation Program in Pittsburgh (protocol PRO08050491). The objective of this study is to study the efficacy and safety of autologous tissue transplantation in patients diagnosed with primary ovarian insufficiency after chemotherapy and/or radiation treatments.

Conditions Studied

Interventions

  • PROCEDURE Ovarian tissue transplant

Study Locations (1)

Pennsylvania

  • Magee-Womens Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2021-03-01
Est. Completion 2027-09-01
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT03496636

The ClinicalTrials.gov registry entry for NCT03496636 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Female Infertility appearing as the primary indexed condition, and to 1 intervention - of which Ovarian tissue transplant is the first listed.

NCT03496636 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03496636 about?

NCT03496636 is a clinical study titled "Autologous Ovarian Tissue Transplantation". Chemotherapy and radiation for cancer and other conditions can cause infertility. Several centers around the world are cryopreserving ovarian tissue from these patients though an experimental protocol, including the Fertility Preservation Program in Pittsburgh (protocol PRO08050491). The objective o...

What is the current status of trial NCT03496636?

This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2021-03-01. Estimated completion is 2027-09-01.

What conditions does trial NCT03496636 study?

This clinical trial studies the following conditions: Female Infertility.

What interventions are being tested in trial NCT03496636?

The interventions under investigation include: Ovarian tissue transplant (PROCEDURE).

Who is sponsoring clinical trial NCT03496636?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03496636 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.